Class information for:
Level 1: HISTONE DEACETYLASE INHIBITOR//HISTONE DEACETYLASE INHIBITORS//HISTONE DEACETYLASE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
264 3709 48.4 91%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
348 16958 DNA METHYLATION//EPIGENETICS//HISTONE DEACETYLASE INHIBITOR

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HISTONE DEACETYLASE INHIBITOR Author keyword 252 49% 10% 371
2 HISTONE DEACETYLASE INHIBITORS Author keyword 172 49% 7% 258
3 HISTONE DEACETYLASE Author keyword 137 31% 10% 375
4 HDAC INHIBITOR Author keyword 110 46% 5% 181
5 VORINOSTAT Author keyword 87 53% 3% 114
6 SAHA Author keyword 74 52% 3% 101
7 HDAC Author keyword 68 28% 6% 206
8 HISTONE DEACETYLASES Author keyword 56 36% 3% 126
9 SUBEROYLANILIDE HYDROXAMIC ACID Author keyword 56 57% 2% 66
10 PANOBINOSTAT Author keyword 52 62% 1% 54

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 HISTONE DEACETYLASE INHIBITOR 252 49% 10% 371 Search HISTONE+DEACETYLASE+INHIBITOR Search HISTONE+DEACETYLASE+INHIBITOR
2 HISTONE DEACETYLASE INHIBITORS 172 49% 7% 258 Search HISTONE+DEACETYLASE+INHIBITORS Search HISTONE+DEACETYLASE+INHIBITORS
3 HISTONE DEACETYLASE 137 31% 10% 375 Search HISTONE+DEACETYLASE Search HISTONE+DEACETYLASE
4 HDAC INHIBITOR 110 46% 5% 181 Search HDAC+INHIBITOR Search HDAC+INHIBITOR
5 VORINOSTAT 87 53% 3% 114 Search VORINOSTAT Search VORINOSTAT
6 SAHA 74 52% 3% 101 Search SAHA Search SAHA
7 HDAC 68 28% 6% 206 Search HDAC Search HDAC
8 HISTONE DEACETYLASES 56 36% 3% 126 Search HISTONE+DEACETYLASES Search HISTONE+DEACETYLASES
9 SUBEROYLANILIDE HYDROXAMIC ACID 56 57% 2% 66 Search SUBEROYLANILIDE+HYDROXAMIC+ACID Search SUBEROYLANILIDE+HYDROXAMIC+ACID
10 PANOBINOSTAT 52 62% 1% 54 Search PANOBINOSTAT Search PANOBINOSTAT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SUBEROYLANILIDE HYDROXAMIC ACID 508 55% 17% 641
2 HDAC INHIBITORS 301 59% 9% 335
3 TRICHOSTATIN A 246 43% 12% 435
4 SAHA 210 82% 3% 121
5 HISTONE DEACETYLASE INHIBITORS 172 22% 19% 710
6 VORINOSTAT 164 63% 4% 163
7 CHROMOBACTERIUM VIOLACEUM NO 968 143 74% 3% 107
8 HISTONE DEACETYLASE INHIBITOR 126 27% 11% 398
9 TRANSFORMED CELL DIFFERENTIATION 119 79% 2% 77
10 HUMAN HDAC8 107 84% 2% 58

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
New and emerging HDAC inhibitors for cancer treatment 2014 90 123 72%
Anticancer activities of histone deacetylase inhibitors 2006 1390 198 71%
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents 2015 5 190 71%
Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy 2015 7 129 38%
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications 2012 139 120 74%
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer 2006 1226 135 49%
Histone deacetylase inhibitors: molecular mechanisms of action 2007 648 109 72%
Histone Deacetylase Inhibitors in Cancer Therapy 2009 402 112 75%
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders 2014 43 265 43%
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents 2010 191 115 77%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MOL GENET PREPARAT MOL BIOL 5 42% 0.3% 10
2 DIPARTIMENTO PATOL GEN 5 15% 0.8% 29
3 DRUG DESIGN OPTIMIZAT MED CHEM 4 75% 0.1% 3
4 GEN CHEM GRP 4 75% 0.1% 3
5 GENEXTRA GRP 3 39% 0.2% 7
6 INTER PROGRAM CHEM BIOL 3 57% 0.1% 4
7 CCU PEDIAT ONCOL G340 3 100% 0.1% 3
8 MOL GENET PRAEPARAT MOL BIOL 3 100% 0.1% 3
9 HEMATOL NEOPLASIA 3 35% 0.2% 7
10 CHEM GENET 3 13% 0.6% 22

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000131229 MEF2C//MEF2//MEF2D
2 0.0000125666 TRAUMA EMERGENCY SURG SURG CRIT CAREMASSAC//HUNAN MED EPIGEN//TOLERANCE BREAKDOWN
3 0.0000092044 ZEBULARINE//DECITABINE//FAZARABINE
4 0.0000072413 MYST//MOZ//HISTONE ACETYLTRANSFERASE
5 0.0000071843 BLEOMYCIN AMPLIFICATION//PHENYLACETATE//ANTINEOPLASTON AS2 1
6 0.0000061187 MIR 1260B//NOUVEL HOP ESTAING//DIETARY COMPOUNDS
7 0.0000056316 SACKLER PROGRAM EPIGENET DEV PSYCHOBIOL//AGING COGNIT DIS//BONNEY 106
8 0.0000051374 ROMO1//ANTICANC MOL ONCOL//NOX 1
9 0.0000048793 BRMS1//BREAST CANCER METASTASIS SUPPRESSOR 1//FDN CANC METASTASIS
10 0.0000046106 HELMINTHOSPORIUM CARBONUM//HOST SPECIFIC TOXIN//BIPOLARIS ZEICOLA